Physician profile
Robert Sanchez
NPI 1174585053
$14,820.42
in general payments reported to CMS, 2019-2025
48 companies · $1,220 in 2025
The $1,220 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,227 · 2020: $2,877 · 2021: $1,364 · 2022: $1,493 · 2023: $1,866 · 2024: $1,774 · 2025: $1,220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,857 · Education: $2.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,856.75 |
| Education | $2.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5,077.41 | 2019-2025 | Lifevest |
| Amgen INC. | $1,027.62 | 2019-2024 | Repatha |
| Pfizer INC. | $1,011.57 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $900.95 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $869.72 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Novartis Pharmaceuticals Corporation | $803.27 | 2019-2025 | |
| Abbott Laboratories | $558.48 | 2019-2025 | Aveir, Diamondback Coronary, Cardiomems |
| Merck Sharp & Dohme LLC | $449.92 | 2021-2024 | Verquvo |
| Amarin Pharma, INC. | $390.68 | 2019-2021 | |
| Esperion Therapeutics, INC. | $388.39 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $376.09 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $286.61 | 2019-2023 | |
| Alnylam Pharmaceuticals INC. | $272.46 | 2024-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $229.43 | 2022-2025 | Wegovy |
| Boston Scientific Corporation | $203.52 | 2021-2025 | Watchman Access System, Bodyguardian, General - Therapies |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $152.49 | 2024 | |
| Vital Connect, INC | $151.06 | 2023 | Vitalpatch Rtm |
| Reflow Medical INC | $135.55 | 2024 | |
| Philips North America LLC | $129.06 | 2020-2025 | (Ck4) Mcot, Extended Holter |
| Shockwave Medical, INC | $119.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $118.25 | 2023-2024 | Inpefa |
| Medtronic, INC. | $114.62 | 2022-2025 | Micra, Mycarelink |
| Kestra Medical Technology Services, INC. | $101.40 | 2023-2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $93.73 | 2020-2025 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $75.20 | 2022-2025 | |
| Arbor Pharmaceuticals, INC. | $71.74 | 2019-2021 | |
| Abiomed | $68.27 | 2024 | Impella |
| Medtronic Vascular, INC. | $52.39 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $52.03 | 2019-2024 | Evkeeza |
| Chiesi USA, INC. | $50.33 | 2020-2024 | Kengreal |
| Bridgebio Pharma, INC. | $49.68 | 2025 | Attruby |
| Scpharmaceuticals INC. | $44.41 | 2025 | |
| Impulse Dynamics (USA) INC. | $40.51 | 2024 | Optimizer |
| Akcea Therapeutics, INC. | $33.29 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $31.95 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $31.82 | 2022-2023 | Uptravi, Opsumit |
| Kiniksa Pharmaceuticals, LTD. | $27.24 | 2022-2023 | Arcalyst |
| Gilead Sciences, INC. | $26.47 | 2019 | |
| Baxter Healthcare | $23.64 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Biotronik INC. | $22.85 | 2022 | |
| Csl Behring | $22.82 | 2019 | |
| Astellas Pharma US INC | $22.71 | 2019 | |
| Portola Pharmaceuticals, LLC | $21.87 | 2020 | |
| Lilly USA, LLC | $21.26 | 2024 | Zepbound |
| Angiodynamics, INC. | $19.23 | 2022 | |
| Genzyme Corporation | $18.88 | 2023 | |
| Endologix LLC | $18.33 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.